Synlett 2008(5): 712-714  
DOI: 10.1055/s-2008-1042805
LETTER
© Georg Thieme Verlag Stuttgart · New York

Facile Synthesis of the C1-C13 Fragment of Lyngbouilloside

Julian Gebauer, Stellios Arseniyadis*, Janine Cossy*
Laboratoire de Chimie Organique, ESPCI, CNRS, 10 Rue Vauquelin, 75231 Paris Cedex 05, France
Fax: +33(1)40794660; e-Mail: janine.cossy@espci.fr; e-Mail: stellios.arseniyadis@espci.fr;
Further Information

Publication History

Received 7 December 2007
Publication Date:
26 February 2008 (online)

Abstract

A highly efficient synthesis of the C1-C13 fragment of the marine macrolide lyngbouilloside is presented starting from commercial (S)-citramalic acid.

8

Compound 3: [α]D 20 -26.2 (c 1.0, CHCl3). 1H NMR (C6D6): δ = 7.29 (d, J = 8.8 Hz, 2 H), 6.90 (d, J = 8.8 Hz, 2 H), 5.92-5.83 (m, 1 H), 5.19-5.14 (m, 2 H), 4.47 (d, J = 11.0 Hz, 1 H), 4.25 (d, J = 11.0 Hz, 1 H), 3.96 (d, J = 8.5 Hz, 1 H), 3.77 (d, J = 8.5 Hz, 1 H), 3.69 (m, 1 H), 3.41 (s, 3 H), 2.74 (m, 1 H), 1.92 (dd, J = 14.3, 3.0 Hz, 1 H), 1.85 (dd, J = 14.3, 9.3 Hz, 1 H), 1.54 (s, 3 H), 1.50 (s, 3 H), 1.40 (s, 3 H), 1.15 (d, J = 7.0 Hz, 3 H). 13C NMR (C6D6): δ = 159.7 (Cq), 141.0 (CH), 131.2 (Cq), 129.5 (CH), 114.9 (CH2), 114.1 (CH), 108.6 (Cq), 80.8 (Cq), 79.3 (CH), 75.8 (CH2), 70.7 (CH2), 54.8 (CH3), 40.5 (CH2), 39.5 (CH), 27.6 (CH3), 27.4 (CH3), 25.0 (CH3), 12.8 (CH3). ESI-HRMS: m/z calcd for C20H30NaO4: 357.2036; found 357.2035.

12

CHIRALPAK AD-H (SFC), MeOH/CO2 = 8:92.

13

The absolute configuration of alcohol 8 was determined by hydrogenation of the terminal double bond and comparison of the optical rotation {[α]D 20 -21.0 (c 1.0, CHCl3)} with the literature {[α]D 20 +19.8 (CHCl3) for the enantiomer}. [10]

14

Compound 4: [α]D 20 +19.0 (c 1.0, CHCl3). 1H NMR (CDCl3): δ = 6.30 (dd, J = 17.8, 10.3 Hz, 1 H), 6.19 (d, J = 17.8 Hz, 1 H), 5.88 (d, J = 10.3 Hz, 1 H), 5.29 (s, 1 H), 4.34 (m, 1 H), 2.80-2.67 (m, 2 H), 2.44-2.29 (m, 2 H), 1.64 (s, 3 H), 1.63 (s, 3 H), 1.50 (br s, 1 H). 13C NMR (CDCl3): δ = 200.3 (Cq), 168.3 (Cq), 161.0 (Cq), 136.4 (CH), 129.8 (CH2), 106.7 (Cq), 95.5 (CH), 64.7 (CH), 45.1 (CH2), 40.5 (CH2), 25.5 (CH3), 24.6 (CH3). ESI-HRMS: m/z calcd for C12H16NaO5: 263.0890; found 263.0885.

16

Compound 9: [α]D 20 -11.5 (c 1.0, CHCl3). 1H NMR (C6D6): δ = 7.34 (d, J = 8.8 Hz, 2 H), 6.92 (d, J = 8.8 Hz, 2 H), 5.42 (s, 1 H), 4.52 (d, J = 11.0 Hz, 1 H), 4.34 (d, J = 11.0 Hz, 1 H), 4.27 (m, 1 H), 3.97 (d, J = 8.5 Hz, 1 H), 3.70 (d, J = 8.5 Hz, 1 H), 3.65 (m, 1 H), 3.44 (s, 3 H), 3.17 (br s, 1 H), 2.26-2.11 (m, 5 H), 2.03-1.94 (m, 3 H), 1.84 (m, 2 H), 1.66 (m, 1 H), 1.55 (s, 3 H), 1.52 (s, 3 H), 1.46 (s, 3 H), 1.45 (s, 3 H), 1.42 (s, 3 H), 0.98 (d, J = 6.7 Hz, 3 H). 13C NMR (C6D6): δ = 209.7 (Cq), 168.0 (Cq), 160.1 (Cq), 159.7 (Cq), 131.2 (Cq), 129.5 (CH), 114.1 (CH2), 108.6 (Cq), 106.3 (Cq), 96.1 (CH), 80.8 (Cq), 79.2 (CH), 75.9 (CH2), 70.6 (CH2), 64.9 (CH2), 54.8 (CH3), 48.4 (CH2), 41.5 (CH2), 40.7 (CH2), 40.2 (CH2), 34.1 (CH), 27.7 (CH3), 27.4 (CH3), 26.9 (CH2), 25.2 (CH3), 25.0 (CH3), 24.4 (CH3), 13.6 (CH3). ESI-HRMS: m/z calcd for C30H44NaO9: 571.2878; found: 571.2870.

18

Compound 2: [α]D 20 -21.8 (c 0.15, CHCl3). 1H NMR (C6D6): δ = 7.34 (d, J = 8.8, 2 H), 6.92 (d, J = 8.8 Hz, 2 H), 5.42 (s, 1 H), 4.52 (d, J = 11.0 Hz, 1 H), 4.34 (d, J = 11.0 Hz, 1 H), 4.28 (m, 1 H), 3.97 (d, J = 8.5 Hz, 1 H), 3.81 (d, J = 8.5 Hz, 1 H), 3.65 (m, 1 H), 3.44 (s, 3 H), 3.17 (br s, 1 H), 2.25-2.10 (m, 5 H), 2.03-1.90 (m, 3 H), 1.84 (m, 2 H), 1.67 (m, 1 H), 1.55 (s, 3 H), 1.52 (s, 3 H), 1.46 (s, 3 H), 1.45 (s, 3 H), 1.42 (s, 3 H), 0.98 (d, J = 6.7 Hz, 3 H). 13C NMR (C6D6): δ = 209.7 (Cq), 168.0 (Cq), 160.1 (Cq), 159.7 (Cq), 131.2 (Cq), 129.5 (CH), 114.1 (CH), 108.6 (Cq), 106.3 (Cq), 96.1 (CH), 80.8 (Cq), 79.2 (CH), 75.9 (CH2), 70.6 (CH2), 65.0 (CH), 54.8 (CH3), 48.4 (CH2), 41.5 (CH2), 40.7 (CH2), 40.2 (CH2), 34.1 (CH), 27.7 (CH3), 27.4 (CH3), 26.9 (CH2), 25.2 (CH3), 25.0 (CH3), 24.4 (CH3), 13.6 (CH3). ESI-HRMS: m/z calcd for C30H46NaO9: 573.3034; found: 573.3024.